Such analysis was described in a recent paper comparing level of LOY in CD34+ blood cells (involved in MDS) with level of LOY in CD3+ T-cells (not involved in MDS) in MDS patients and controls of different ages (Ganster et al. 2015). The gene discussed is CD34; the disease is myelodysplastic syndrome.